Adrenochrome Monosemicarbazone

Adrenochrome Monosemicarbazone Pharmacology
 
Adrenochrome Monosemicarbazone
About Adrenochrome Monosemicarbazone
Antihemorrhagic, an oxidation product of adrenaline.
Mechanism of Action of Adrenochrome Monosemicarbazone
The drug acts as a haemostatic agent by reducing capillary fragility. It controls oozing from raw surfaces and prevent bleeding from microvasculature.
Pharmacokinets of Adrenochrome Monosemicarbazone
N/A
Onset of Action for Adrenochrome Monosemicarbazone
N/A
Duration of Action for Adrenochrome Monosemicarbazone
N/A
Half Life of Adrenochrome Monosemicarbazone
N/A
Side Effects of Adrenochrome Monosemicarbazone
N/A
Contra-indications of Adrenochrome Monosemicarbazone
Hypersensitivity to the drug.
Special Precautions while taking Adrenochrome Monosemicarbazone
Hepatic impairment: Use with caution
Pregnancy Related Information
Use with caution.
Old Age Related Information
Use with caution.
Breast Feeding Related Information
Use with caution.
Children Related Information
Use with caution.
Indications for Adrenochrome Monosemicarbazone
1. Epistaxis
2. Haematuria
3. Secondary haemorrhage from wounds,
4. Retinal haemorrhage
5. Menorrhagia
6. Metrorrhagia
7. Prior to surgery to reduce bleeding.
Interactions for Adrenochrome Monosemicarbazone
Antihistaminics: Reduce the efficacy of adrenochrome semicarbazone.
Typical Dosage for Adrenochrome Monosemicarbazone
Oral: 1 to 2 tablets: 8th hourly
Parenteral: 5 to 10mg 8th hourly I.M.
Children: Half the adult dose
Schedule of Adrenochrome Monosemicarbazone
N/A
Storage Requirements for Adrenochrome Monosemicarbazone
Store in airtight containers and protects from light.
Effects of Missed Dosage of Adrenochrome Monosemicarbazone
Take the missed dose as soon as noticed and if it is the time for next dose then skip the missed dose. Continue the regular schedule. Do not double the dose.
Effects of Overdose of Adrenochrome Monosemicarbazone
Give supportive measures and symptomatic treatment.

 

Leave a Reply

Your email address will not be published. Required fields are marked *

Enable Notifications OK No thanks